GlassScriptPhysician profile
Lauren Hammer
NPI 1720431968
$2,984.98
in general payments reported to CMS, 2019-2025
26 companies · $547 in 2025
The $547 reported for 2025 was more than what 88% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $573 · 2023: $859 · 2024: $841 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,148 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,147.82 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $461.59 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $354.63 | 2021-2025 | |
| Exeltis, USA INC. | $270.25 | 2021-2025 | Slynd |
| Abbvie INC. | $240.63 | 2021-2024 | |
| Myovant Sciences INC. | $183.91 | 2021-2022 | |
| Coopersurgical, INC. | $164.79 | 2022-2024 | Endosee |
| Shield Therapeutics INC | $151.23 | 2023-2025 | Accrufer |
| Pfizer INC. | $148.14 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $136.61 | 2023-2024 | Myfembree |
| Sage Therapeutics, LLC | $125.77 | 2022-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $117.25 | 2021-2025 | |
| Organon LLC | $106.68 | 2022-2025 | Nexplanon |
| Agile Therapeutics, INC. | $73.74 | 2022-2024 | Twirla |
| Smith+Nephew, INC. | $53.58 | 2024-2025 | Pico 14 |
| Merck Sharp & Dohme LLC | $52.62 | 2023-2024 | Gardasil 9, Gardasil |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $47.38 | 2024-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Millicent US INC | $45.43 | 2024 | Intrarosa |
| Avion Pharmaceuticals | $38.72 | 2022-2023 | Balcoltra |
| Channel Medsystems, INC. | $38.14 | 2022 | |
| Evofem Biosciences, INC. | $37.48 | 2022 | |
| Ascend Therapeutics US, LLC | $35.52 | 2023-2024 | |
| Gynesonics, INC. | $28.49 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Novo Nordisk INC | $20.17 | 2024 | |
| Mylan Pharmaceuticals INC. | $19.52 | 2022 | |
| Medtronic, INC. | $19.07 | 2023 | Truclear |
| Therapeuticsmd, INC. | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Hammer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.